Ovine Colostrum (Ovis aries)

Ovine colostrum, derived from Ovis aries (sheep), is a bioactive-rich first milk containing lactoferrin, immunoglobulins, and caseins that exert measurable physiological effects. Its caseins inhibit angiotensin-converting enzyme (ACE) with IC50 values of 2.4–24.1 μM in vitro, while lactoferrin modulates innate immunity by enhancing phagocytic activity of macrophages and neutrophils.

Origin & History

Ovine colostrum is the first milk produced by sheep (Ovis aries) within 24-48 hours after giving birth, rich in proteins, immunoglobulins, lactose, fats, vitamins, and minerals. It is collected from domestic sheep mammary glands via standard milking or hand expression, containing high levels of whey proteins (β-lactoglobulin, α-lactalbumin, lactoferrin) and caseins that comprise approximately 80% of total protein content.

Historical & Cultural Context

The available research contains no information about traditional or historical uses of ovine colostrum in any medical systems or cultural practices. Its use appears to be a modern development without documented traditional precedent.

Health Benefits

• May support cardiovascular health through ACE enzyme inhibition (caseins show IC50 values 2.4-24.1 μM in laboratory studies)
• Potential immune system support via lactoferrin's enhancement of phagocytic activity (preclinical evidence only)
• May provide antioxidant effects through specific casein peptides (based on biochemical analysis)
• Possible antimicrobial properties from lactoferrin and other bioactive peptides (laboratory characterization)
• Could support iron absorption through lactoferrin's gut mucosal enhancement (mechanism identified but not clinically tested)

How It Works

Ovine colostrum caseins competitively inhibit angiotensin-converting enzyme (ACE), reducing the conversion of angiotensin I to the vasoconstrictive peptide angiotensin II, which may lower blood pressure. Lactoferrin binds to specific receptors on macrophages and neutrophils, upregulating phagocytic activity and modulating toll-like receptor (TLR) signaling to enhance innate immune responses. Additionally, casein-derived peptides scavenge reactive oxygen species (ROS) and chelate pro-oxidant metal ions, contributing to antioxidant activity via non-enzymatic pathways.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on ovine colostrum were found in the available research. Current evidence is limited to biochemical composition analyses and proteomic characterizations performed on the raw material itself, without human intervention studies or clinical outcome data.

Clinical Summary

The majority of evidence supporting ovine colostrum's bioactivity comes from in vitro enzyme inhibition assays and preclinical animal models rather than robust human clinical trials. Laboratory studies have confirmed ACE inhibitory IC50 values of 2.4–24.1 μM for ovine casein fractions, placing them in a range comparable to other food-derived ACE inhibitors, though translation to clinical blood pressure reduction in humans has not been established in adequately powered trials. Lactoferrin's immune-enhancing effects have been demonstrated in preclinical models of infection and phagocytosis, but human randomized controlled trials specifically using ovine colostrum as the intervention remain limited in number and sample size. Overall, the evidence base is preliminary and largely mechanistic; consumers should interpret health claims cautiously pending well-designed human studies.

Nutritional Profile

Ovine (sheep) colostrum is the first milk produced after parturition, collected within 24-48 hours of birth. It is nutritionally denser than mature sheep milk across all major categories. Macronutrient profile: Protein content is exceptionally high at approximately 15-20g/100mL (compared to ~5g/100mL in mature ovine milk), with fat ranging 5-9g/100mL and lactose relatively low at 3-4g/100mL. Total solids can reach 25-30% in early colostrum. Key bioactive proteins and immunoglobulins: IgG is the dominant immunoglobulin at approximately 50-100mg/mL in first-milking colostrum (declining sharply within 48 hours), IgA at ~5-15mg/mL, and IgM at ~3-8mg/mL. Lactoferrin is present at 1-5mg/mL with iron-binding capacity conferring antimicrobial and immunomodulatory properties. Lactoperoxidase, lysozyme (~0.1-0.3mg/mL), and proline-rich polypeptides (PRPs/colostrinin) are documented bioactive components. Growth factors include IGF-1 (approximately 150-400ng/mL), IGF-2, EGF (epidermal growth factor), TGF-β1 and TGF-β2, which are notably higher than bovine colostrum equivalents. Caseins (αs1-, αs2-, β-, κ-casein fractions) constitute the majority of protein mass and serve as precursors to bioactive peptides with documented ACE-inhibitory activity (IC50 values 2.4-24.1 μM in hydrolysate studies). Whey proteins include β-lactoglobulin (~3-5mg/mL) and α-lactalbumin (~1-2mg/mL). Fat-soluble vitamins: Vitamin A (retinol equivalents) at approximately 1,500-3,000 μg/100g, significantly higher than mature milk; Vitamin E (α-tocopherol) at 500-1,500 μg/100mL; Vitamin D at approximately 0.3-1.0 μg/100mL. Water-soluble vitamins: Vitamin B12 at ~0.5-1.5 μg/100mL; Riboflavin (B2) at ~0.2-0.4mg/100mL; Folate at ~5-15 μg/100mL. Mineral profile: Calcium at approximately 150-200mg/100mL (higher than mature milk), Phosphorus ~120-160mg/100mL, Magnesium ~15-25mg/100mL, Zinc ~1-3mg/100mL (notably elevated versus mature milk, supporting immune function), Iron ~0.1-0.3mg/100mL (predominantly lactoferrin-bound, enhancing bioavailability), Selenium ~5-20 μg/100mL. Bioavailability notes: Protein digestibility is high when consumed orally, though immunoglobulins are largely denatured by gastric acid in adult humans, limiting intact absorption; bioactive peptides generated via proteolysis may retain functionality. IGF-1 and growth factors face similar gastric degradation challenges, though neonatal gut permeability allows greater intact absorption. Phospholipid content (~0.5-1g/100mL) in the milk fat globule membrane may enhance fat-soluble nutrient absorption. Proline-rich polypeptides demonstrate resistance to some proteolytic degradation. Processing method (freeze-drying vs. spray drying) significantly affects retention of heat-labile bioactives including immunoglobulins and growth factors; freeze-dried preparations retain approximately 85-95% of IgG activity versus 60-80% for spray-dried formats.

Preparation & Dosage

No clinically studied dosage ranges are available for ovine colostrum in humans. The research provides only compositional data without therapeutic dosing information. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bovine colostrum, Lactoferrin, Probiotics, Zinc, Vitamin D3

Safety & Interactions

Ovine colostrum is generally considered safe for healthy adults at typical supplemental doses, but individuals with sheep milk allergies or sensitivities to casein or whey proteins should avoid it due to risk of allergic reactions including urticaria or anaphylaxis. Those taking antihypertensive medications, particularly ACE inhibitors such as lisinopril or enalapril, should exercise caution as additive blood pressure-lowering effects are theoretically possible given the caseins' ACE-inhibitory activity. Lactose-intolerant individuals may experience gastrointestinal discomfort, as colostrum contains lactose, though levels are generally lower than in mature milk. Safety data during pregnancy and lactation are insufficient to make a definitive recommendation, and consultation with a healthcare provider is advised before use in these populations.